Australia markets open in 8 hours 40 minutes

Elixinol Wellness Limited (ELLXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0038+0.0003 (+8.57%)
At close: 12:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.02M
Enterprise value 5.37M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.43
Price/book (mrq)1.19
Enterprise value/revenue 0.65
Enterprise value/EBITDA -0.79

Trading information

Stock price history

Beta (5Y monthly) 2.07
52-week change 3-72.46%
S&P500 52-week change 320.07%
52-week high 30.0211
52-week low 30.0025
50-day moving average 30.0060
200-day moving average 30.0065

Share statistics

Avg vol (3-month) 3101.25k
Avg vol (10-day) 3179.13k
Shares outstanding 51.3B
Implied shares outstanding 61.32B
Float 8536.76M
% held by insiders 19.42%
% held by institutions 16.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -90.79%
Operating margin (ttm)-58.68%

Management effectiveness

Return on assets (ttm)-29.99%
Return on equity (ttm)-96.12%

Income statement

Revenue (ttm)8.27M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)25.40%
Gross profit (ttm)N/A
EBITDA -5.92M
Net income avi to common (ttm)-7.51M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)708k
Total cash per share (mrq)0
Total debt (mrq)1.26M
Total debt/equity (mrq)19.53%
Current ratio (mrq)1.64
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-2.76M
Levered free cash flow (ttm)-2.11M